Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
NSPR
#3171
InspireMD, Inc.
1.7
8
-2.73%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-2.73%
Changement Mensuel
+7.88%
Evolution sur 6 mois
-27.35%
Changement Annuel
-46.39%
Clôture Précédente
1.8
3
Open
1.7
8
Bid
Ask
Low
1.7
7
High
1.7
9
Volume
4
Marchés
Actions des Marchés US
Soins de Santé
NSPR
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
7.86 M
8.32 M
8.33 M
23.46 M
29.69 M
—
Valuation ratios
Enterprise value
—
13.13 M
2.99 M
53.93 M
59.17 M
251.1 M
Price to earnings ratio
—
—
0.39
-3.3
-3.46
-12.81
Price to sales ratio
—
—
1.39
10.6
15.73
63.92
Price to cash flow ratio
—
—
0.46
4.02
5.04
17.29
Price to book ratio
—
—
0.41
1.66
3.06
5.55
Enterprise value to EBITDA ratio
—
—
—
-2.58
-1.74
-6.37
Profitability ratios
Return on assets %
-0.59
-0.38
-0.75
-0.42
-0.68
-1.04
Return on equity %
-0.87
-0.44
-1.06
-0.5
-0.89
-1.5
Return on invested capital %
-2 732.34
-493.64
-408.16
-1 005.55
-3 649.78
—
Gross margin %
3.34
16.77
21.6
29.12
21.49
95.01
Operating margin %
-417.71
-327.39
-361.88
-340.74
-478
-2 479.62
EBITDA margin %
—
—
—
-337
-485.49
-2 509.21
Net margin %
-424.31
-331.88
-357.59
-320.97
-456.63
-2 444.32
Liquidity ratios
Quick ratio
3.76
8.27
3.89
6.99
4.94
17.57
Current ratio
4.14
8.53
4.21
7.34
5.28
18.96
Inventory turnover
1.81
2.92
2.93
2.36
2.35
2.05
Asset turnover
0.18
0.16
0.16
0.17
0.15
0.17
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-1.97
-0.67
-0.52
-0.65
EBIT per share
—
—
-2.38
-0.87
-0.82
-0.95
EBITDA per share
—
—
—
-0.86
-0.81
-0.95
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
0.59
1.61
0.83
2.82
Net current asset value per share
—
—
2.71
1.82
0.97
3.32
Tangible book value per share
—
—
2.21
1.63
0.86
2.93
Working capital per share
—
—
2.07
1.57
0.78
2.63
Book value per share
—
—
2.21
1.63
0.86
2.93
Nouvelles
Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates
Lake Street maintient sa recommandation sur InspireMD, citant la croissance du marché
Lake Street reiterates InspireMD stock rating citing market growth
Le directeur commercial d’InspireMD, Gleason, vend des actions NSPR pour 99k€
InspireMD CCO Gleason sells $99k in NSPR stock
InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates
Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates
InspireMD nomme Dr. Peter Soukas au poste de directeur médical
InspireMD appoints Dr. Peter Soukas as chief medical officer
Intuitive Surgical, Inc. (ISRG) Q3 Earnings and Revenues Top Estimates
Stifel reprend la couverture de l’action Beta Bionics avec une recommandation d’achat
Goldman Sachs relève Beta Bionics à l’achat en misant sur la croissance des technologies du diabète